Dr. Diego de Mendoza is an Investigator of the National Research Council of Argentina (CONICET). The group of Dr. de Mendoza studies the basic principles of how the biosynthesis of lipid is regulated and how these molecules are involved in the organization and functioning of membrane and signaling processes in prokaryotic and eukaryotic organisms. The group of Dr. de Mendoza is as a world leader in the field of bacterial lipids. More recently, using C. elegans as a model system and applying a variety of genetic and biochemical methods, his group is investigating the role of lipids as intracellular signals in neurodegenerative disorders. Dr. de Mendoza was an international Research Scholar of the Howard Hughes Medical Institute (HHMI) from 2002 to 2011, is a member of the American Academy of Microbiology and the European Molecular Biology Organization (EMBO). He has been distinguished for his work with the Guggenheim Fellowship, the Alexander von Humboldt Award, the prize Investigator of the Argentine Nation, granted by the President of Argentina, the prize Bunge and Born trajectory and the Konex Platinum Award, among others.
De Mendoza, Diego
De Mendoza, Diego
Group Director, Senior Researcher
Laboratory:
Biochemistry and Metabolic Regulation
Sede:
CCT
Teléfono:
634
